These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18027904)

  • 21. Tetrahydro-β-carboline derivatives targeting fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channels.
    Ortar G; De Petrocellis L; Moriello AS; Allarà M; Morera E; Nalli M; Di Marzo V
    Bioorg Med Chem Lett; 2013 Jan; 23(1):138-42. PubMed ID: 23206861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
    Karbarz MJ; Luo L; Chang L; Tham CS; Palmer JA; Wilson SJ; Wennerholm ML; Brown SM; Scott BP; Apodaca RL; Keith JM; Wu J; Breitenbucher JG; Chaplan SR; Webb M
    Anesth Analg; 2009 Jan; 108(1):316-29. PubMed ID: 19095868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
    Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors.
    Millns PJ; Chimenti M; Ali N; Ryland E; de Lago E; Fernandez-Ruiz J; Chapman V; Kendall DA
    Eur J Neurosci; 2006 Dec; 24(12):3489-95. PubMed ID: 17229097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.
    Gouveia-Figueira S; Karlsson J; Deplano A; Hashemian S; Svensson M; Fredriksson Sundbom M; Congiu C; Onnis V; Fowler CJ
    PLoS One; 2015; 10(9):e0139212. PubMed ID: 26406890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty pain cures.
    Imming P
    Chem Biol; 2007 Dec; 14(12):1311-2. PubMed ID: 18096498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-arachidonoyl-serotonin in the basolateral amygdala increases anxiolytic behavior in the elevated plus maze.
    John CS; Currie PJ
    Behav Brain Res; 2012 Aug; 233(2):382-8. PubMed ID: 22633963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists.
    Brown BS; Keddy R; Zheng GZ; Schmidt RG; Koenig JR; McDonald HA; Bianchi BR; Honore P; Jarvis MF; Surowy CS; Polakowski JS; Marsh KC; Faltynek CR; Lee CH
    Bioorg Med Chem; 2008 Sep; 16(18):8516-25. PubMed ID: 18722778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
    J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of FAAH, TRPV1, and COX2 by NSAID-serotonin conjugates.
    Rose TM; Reilly CA; Deering-Rice CE; Brewster C; Brewster C
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5695-5698. PubMed ID: 25467164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of CB
    Sartim AG; Moreira FA; Joca SRL
    Neuroscience; 2017 Jan; 340():126-134. PubMed ID: 27771531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arylboronic acids as dual-action FAAH and TRPV1 ligands.
    Morera E; Di Marzo V; Monti L; Allarà M; Schiano Moriello A; Nalli M; Ortar G; De Petrocellis L
    Bioorg Med Chem Lett; 2016 Mar; 26(5):1401-5. PubMed ID: 26850005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-palmitoyl-vanillamide (palvanil) is a non-pungent analogue of capsaicin with stronger desensitizing capability against the TRPV1 receptor and anti-hyperalgesic activity.
    De Petrocellis L; Guida F; Moriello AS; De Chiaro M; Piscitelli F; de Novellis V; Maione S; Di Marzo V
    Pharmacol Res; 2011 Apr; 63(4):294-9. PubMed ID: 21215315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
    Vandevoorde S; Fowler CJ
    Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase.
    Cisneros JA; Vandevoorde S; Ortega-Gutiérrez S; Paris C; Fowler CJ; López-Rodríguez ML
    J Med Chem; 2007 Oct; 50(20):5012-23. PubMed ID: 17764163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
    Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
    Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of indole-based peptoids as potent noncompetitive antagonists of transient receptor potential vanilloid 1.
    Quintanar-Audelo M; Fernández-Carvajal A; Van Den Nest W; Carreño C; Ferrer-Montiel A; Albericio F
    J Med Chem; 2007 Nov; 50(24):6133-43. PubMed ID: 17985859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands.
    Morera E; De Petrocellis L; Morera L; Moriello AS; Ligresti A; Nalli M; Woodward DF; Di Marzo V; Ortar G
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6806-9. PubMed ID: 19875281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel dual-target FAAH and TRPV1 ligands as potential pharmacotherapeutics for pain management.
    Qiao Z; Liu S; Zhai W; Jiang L; Ma Y; Zhang Z; Wang B; Shao J; Qian H; Zhao F; Yan L
    Eur J Med Chem; 2024 Mar; 267():116208. PubMed ID: 38325006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamides, vanillylamides, ethanolamides, and arachidonic acid amides of anti-inflammatory and analgesic drug substances as TRPV1 ligands.
    Sinning C; Watzer B; De Petrocellis L; Di Marzo V; Imming P
    ChemMedChem; 2008 Dec; 3(12):1956-64. PubMed ID: 19003845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.